SAB Biotherapeutics SABS Earnings Call Transcripts

NASDAQ SABS
$3.11 +0.04 (+1.30%)
At close: Nov 11, 2026 · 4:00 PM EST
1 earnings call on file for SAB Biotherapeutics, Q3 2026. Each transcript opens in a new tab.
Latest earnings call

SAB Biotherapeutics Q3 2026 Earnings Call

Nov 5, 2026 3,506 words · 15 min read
  • Samuel ReichChief Executive Officer
  • Lucy ToChief Financial Officer
  • Eddie SullivanCo-Founder and President
  • Alexandra KropotovaChief Medical Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

SAB Biotherapeutics Earnings Call Transcripts

Calls1
LatestNov 5, 2026
SinceQ3 2026

Fiscal 2026

All 1 SAB Biotherapeutics transcript Register to get access to SAB Biotherapeutics’s earnings call transcripts.